Skip to content
Download PDF

Point-of-Care Ultrasound

Chapter 493 | Part 20: Emerging Topics in Clinical Medicine · Parts 19-20 – Consultative & Emerging Topics · Chapter 493

Key Clinical Points

  1. POCUS is defined as the acquisition, interpretation, and clinical integration of ultrasonographic views by a treating clinician in real time at the patient's bedside.
  2. POCUS is distinct from consultative ultrasound, which involves a sonographer acquiring images and an imaging specialist (radiologist/cardiologist) providing the interpretation.
  3. The goal of POCUS is to improve immediate diagnostic and therapeutic decisions, not to replace high-resolution CT or MRI.
  4. Cardiac POCUS utilizes 5 core views: parasternal long-axis, parasternal short-axis (mid-ventricular or papillary muscle level), apical four-chamber, subcostal four-chamber, and inferior vena cava.
  5. Lung ultrasound hallmarks include lung sliding (respirophasic movement), A-lines (horizontal reverberation artifacts), and B-lines (vertical hyperechoic lines).
  6. A noncompressible vein is diagnostic of deep-vein thrombosis (DVT); visualization of intraluminal clot is not required.
  7. POCUS can detect as little as 100–500 mL of peritoneal free fluid and has high sensitivity/specificity for diagnosing abdominal aortic aneurysm (AAA).
  8. Small-bowel obstruction (SBO) criteria: dilation (>2.5 cm), fluid-filled loops (with plicae circularis), and hyperactive to-and-fro peristalsis.
  9. POCUS distinguishes abscess from cellulitis; cellulitis is identified by 'cobblestoning' (subcutaneous edema).
  10. Ultrasound guidance for central venous catheter (CVC) and peripheral intravenous (PIV) insertion improves success rates and reduces complications like pneumothorax or arterial puncture.

1. DEFINITION & OVERVIEW

• Definition: Point-of-care ultrasound (POCUS) is the acquisition, interpretation, and clinical integration of ultrasonographic views by a treating clinician in real time at the patient's bedside. • Distinction from Consultative Ultrasound: ◦ Consultative: Clinician orders → Sonographer acquires → Specialist (Radiologist/Cardiologist) interprets → Report provided to clinician. ◦ POCUS: Clinician performs all steps (Acquire → Interpret → Act) in a single workflow. • Clinical Goal: Improve diagnostic and therapeutic decisions; not intended to replace high-resolution CT or MRI. • Hardware & Technology: ◦ Cart-based machines vs. handheld devices (wired/wireless probes to tablet/mobile phone). ◦ Linear probes: High frequency, excellent resolution, limited penetration (used for superficial structures). ◦ Curvilinear/Phased-array probes: Lower frequency, used for deeper structures. ◦ Capabilities: 2D/grayscale imaging, color flow, and spectral Doppler. • Historical Context: ◦ Entered trauma care in the 1980s; expanded to other specialties since the 2000s. ◦ AMA Resolution (HR. 802) in 1999 allowed specialty-specific scope and credentialing. • Clinical Utility: Enhances accuracy, monitoring, screening, and procedural safety; improves patient/clinician confidence.

2. EPIDEMIOLOGY

• Historical Adoption: Emerged in trauma care (1980s) and expanded to various specialties since the 2000s. • Regulatory Framework: AMA HR. 802 allows specialty-specific scope, credentialing processes, and standard scanning protocols.

3. ETIOLOGY & PATHOPHYSIOLOGY

• Note: POCUS is a clinical diagnostic/procedural tool; etiology and pathophysiology are not applicable.

4. CLINICAL FEATURES

• Cardiac Findings: ◦ LV systolic function: Normal, hyperdynamic, moderately reduced, or severely reduced. ◦ Critical findings: Acute RV failure, cardiac tamponade, gross valvular abnormalities (severe tricuspid/mitral/aortic regurgitation, large vegetations). • Lung/Pleura Findings: ◦ Lung sliding (respirophasic movement), A-lines (horizontal reverberation), B-lines (vertical hyperechoic lines). ◦ Consolidation: Tissue-dense lung; associated with pneumonia if mobile air bronchograms or color flow Doppler are present. ◦ Pleural Effusion: Quantified as small/moderate/large; qualitatively assessed as simple, homogeneously echogenic, complex nonseptated, or complex septated. • Abdominal Findings: ◦ Peritoneal fluid (100–500 mL), AAA, SBO, urinary retention. • Vascular/Soft Tissue Findings: ◦ DVT (noncompressible vein), SSTIs (cellulitis, phlegmon, abscess, necrotizing fasciitis).

5. DIFFERENTIAL DIAGNOSIS

• Role of POCUS: Used to narrow the differential diagnosis and guide workup following history and physical examination. • Clinical Integration: Results are integrated into treatment plans, including bedside procedures performed under ultrasound guidance.

6. INVESTIGATIONS & DIAGNOSIS

6.1 Cardiac Investigations

• Core Views: 1. Parasternal long-axis 2. Parasternal short-axis (mid-ventricular or papillary muscle level) 3. Apical four-chamber 4. Subcostal four-chamber 5. Inferior vena cava • Clinical Utility: ◦ Categorize shock states: LV systolic function (normal, hyperdynamic, moderately reduced, or severely reduced). ◦ Identify immediate management changes: RV failure, tamponade, gross valvular abnormalities.

6.2 Lung and Pleura Investigations

• Normal Aeration Markers: ◦ Lung sliding: Respirophasic movement of parietal/visceral pleural interface. ◦ A-lines: Horizontally oriented reverberation artifacts deep to the pleural line. • Abnormal Findings: ◦ B-lines: Vertically oriented hyperechoic lines from pleural line to bottom of screen (indicate pulmonary edema, pneumonitis, ARDS, or ILD). ◦ Consolidation: Tissue-dense lung; presence of mobile air bronchograms or color flow Doppler suggests pneumonia. • Pleural Effusion: ◦ Identification: Hypoechoic space bounded by diaphragm, chest wall, and atelectatic lung. ◦ Assessment: Quantified (small/moderate/large) and qualitatively graded (simple, homogeneously echogenic, complex nonseptated, or complex septated).

6.3 Abdominal Investigations

• Peritoneal Fluid: ◦ Detection: Can detect 100–500 mL of fluid (cannot specify type). ◦ Procedure Guidance: Identifies safe site for paracentesis; excludes attempts if volume is insufficient. • Urinary System: ◦ Bladder: Confirms presence/absence of urine and catheter function; more reliable than automated scanners. ◦ Hydronephrosis: Detects and grades to identify obstructive uropathy. • Aortic Aneurysm (AAA): ◦ Detection: High sensitivity/specificity; requires protocol for full visualization from celiac trunk to iliac bifurcation in both transverse and longitudinal planes. • Small-Bowel Obstruction (SBO): ◦ Diagnostic Criteria: 1. Dilation (diameter >2.5 cm) 2. Fluid-filled loops (confirmed by appearance of plicae circularis) 3. Hyperactive to-and-fro peristalsis ◦ Clinical Utility: Expedites surgical consultation for new SBO; reduces radiation for recurrent SBO.

6.4 Vascular and Soft Tissue Investigations

• Deep Vein Thrombosis (DVT): 1. Technique: 2D compression ultrasound. 2. Criteria: Noncompressible vein → Diagnostic of DVT (intraluminal clot visualization not required). 3. Location: Performed at major branchpoints due to high turbulence. • Skin and Soft Tissue Infections (SSTI): ◦ Differentiation: Distinguishes SSTI from lymph nodes, seromas, hematomas, hernias, thrombophlebitis, DVT, cysts, and bursitis. ◦ Cellulitis: Identified by 'cobblestoning' (subcutaneous edema). ◦ Abscess: Irregular, enclosed areas with compressible material and absent central flow on color Doppler.

7. MANAGEMENT & TREATMENT

7.1 Procedural Guidance

• Central Venous Catheter (CVC): 1. Sites: Femoral, internal jugular, and axillary veins. 2. Benefits: Improved success rates; reduced complications (pneumothorax, arterial puncture). 3. Procedure: Pre-procedure survey → identify vessels/thrombosis → real-time needle tip visualization → sonographic confirmation of guidewire target. • Peripheral IV (PIV) Guidance: 1. Application: Used for difficult PIV placement or after failed standard attempts. 2. Benefits: Increased success, reduced time to cannulation, and less trauma to surrounding structures. 3. Criteria: Identify large, linear, superficial veins; real-time visualization of needle tip entering lumen.

7.2 Monitoring and Screening

• Serial Monitoring: Used for serial assessment of heart disease or response to treatment. • Screening: Used for AAA screening in high-risk patients to reduce morbidity/mortality.

8. PROGNOSIS & COMPLICATIONS

• Safety Improvements: POCUS reduces risk of pneumothorax and arterial puncture during CVC placement. • Efficiency: Reduces radiation exposure for recurrent SBO; avoids unnecessary incision/drainage in SSTIs.

9. SPECIAL CONSIDERATIONS

9.1 Training and Education

• Process: Longitudinal training required during residency and for in-practice internists. • Scope: Training allows clinicians to perform focused exams (e.g., cardiac) to guide immediate management.

9.2 Credentialing and Privileges

• Governance: Governed by hospital rules. • Categories: 1. Core privileges (e.g., CVC insertion). 2. Add-on privileges (e.g., nerve blocks).

10. KEY PEARLS & CLINICAL TRAPS

• DVT Diagnosis: A noncompressible vein is sufficient for DVT diagnosis; no clot visualization required. • SBO Threshold: Bowel diameter >2.5 cm is the specific threshold for dilation. • Ascites Volume: POCUS can detect as little as 100–500 mL of fluid. • Lung Ultrasound: A-lines = normal; B-lines = abnormal (pulmonary edema/pneumonitis); Lung sliding = normal. • SSTI Differentiation: 'Cobblestoning' identifies cellulitis; absent central flow in an enclosed area identifies abscess.